Clinical trial Recruiting at 1 site Interventional Ages 50 to 85

Comparing autonomic function in patients with cognitive decline

Official title: Evaluation of the Prevalence of Autonomic Nervous System Involvement in Patients With Cognitive Impairment by a Non-invasive Combined Study of Dysautonomia

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06292741 · Data updated 2026-11-12

This study is testing how well a device can measure the automatic functions of the body in people aged 50 to 85 who have mild cognitive decline, like mild dementia or Alzheimer's, to better understand their condition.

Quick facts

Study typeInterventional
Ages50 Years to 85 Years
SexAll
Enrollment120 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Rome, Lazio)
StatusRecruiting
StartedJanuary 11, 2023
Main results expectedOctober 2026
Study endsJanuary 2027
Registry record updatedSeptember 2, 2026
Trial IDNCT06292741 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are males and females aged 50 to 85 with mild cognitive decline due to various forms of dementia.

Probably not a fit

Patients with severe cognitive decline, diabetes, heart disease, or other significant medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to evaluate autonomic parameters in patients experiencing various forms of cognitive decline, including mild dementia and Alzheimer's disease. Participants will use a device called Sudoscan to assess their autonomic function. The study will include individuals aged 50 to 85 who can maintain an upright position and have mild cognitive impairment. By comparing these parameters across different types of cognitive decline, the study seeks to enhance understanding of autonomic involvement in dementia.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools and treatment strategies for patients with cognitive decline.

How similar studies have gone: While this approach is relatively novel, similar studies exploring autonomic function in dementia have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* male and females between 50 and 85 years
* cognitive decline (dementia, lewy's body dementia, Parkinson dementia, Alzheimer dementia)
* mild cognitive decline ( lewy's body MCI, Parkinson MCI and Alzheimer MCI)
* Ability to assume the upright position

Exclusion Criteria:

* diabetes mellitus
* eye problems
* severe cognitive decline
* heart disease
* peripheral neuropathy
* language barrier
* oncological disease
* medical pathologies associated with cognitive deficits

Where it's running

  • Clinica della memria- Fondazione Policlinico Agostino Gemelli IRCCS
    Rome, Lazio, Italy
    Recruiting

Study contacts

  • Principal investigator: Camillo Marra, MD — Memory clinic- Policlinico Agostino Gemelli, IRCCS, Università Cattolica del Sacro Cuore I
  • Study coordinator: Camillo Marra, MD
  • Email: camillo.marra@policlinicogemelli.it
  • Phone: 0630154333

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.